EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 376 filers reported holding EXELIXIS INC in Q2 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $449,378 | -4.6% | 19,999 | +0.8% | 0.01% | -16.7% |
| Q1 2024 | $471,017 | -3.7% | 19,849 | -2.7% | 0.01% | -14.3% |
| Q4 2023 | $489,228 | +11.5% | 20,393 | +1.5% | 0.01% | 0.0% |
| Q3 2023 | $438,792 | +16.2% | 20,082 | +1.6% | 0.01% | +16.7% |
| Q2 2023 | $377,747 | -23.5% | 19,767 | -22.3% | 0.01% | -33.3% |
| Q1 2023 | $493,985 | +21.4% | 25,450 | +0.3% | 0.01% | +28.6% |
| Q4 2022 | $406,903 | +29.2% | 25,368 | +26.4% | 0.01% | 0.0% |
| Q3 2022 | $315,000 | -29.4% | 20,075 | -6.2% | 0.01% | -22.2% |
| Q2 2022 | $446,000 | – | 21,405 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 11,275,871 | $254,722,000 | 71.55% |
| GREAT POINT PARTNERS LLC | 1,201,100 | $27,133,000 | 5.61% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 886,534 | $20,027,000 | 5.30% |
| Sargent Investment Group, LLC | 498,350 | $11,258,000 | 2.96% |
| CAPITAL MANAGEMENT CORP /VA | 311,660 | $7,040,000 | 1.57% |
| EULAV Asset Management | 2,460,000 | $55,571,000 | 1.49% |
| CM Management, LLC | 80,000 | $1,807,000 | 1.34% |
| Integral Health Asset Management, LLC | 200,000 | $4,518,000 | 1.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 10,750,000 | $242,843,000 | 1.21% |
| Sofinnova Investments, Inc. | 839,181 | $18,957,000 | 1.14% |